Deretta C.  Rhodes net worth and biography

Deretta Rhodes Biography and Net Worth

Dr. DeRetta C. Rhodes is a Chief Culture Officer & Executive Vice President at Atlanta Braves Holdings, Inc., a Chief Culture Officer & Executive Vice President at Braves Holdings LLC and a Chairman at 21st Century Leaders. She is on the Board of Directors at The Society for Human Resource Management/SHRM-Atlanta, Inc., Atlanta Braves Foundation, Inc. and The Woodruff Arts Center. Dr. Rhodes was previously employed as a Vice Chairman by Goodwill of North Georgia, Inc. She received her undergraduate degree from the University of Georgia, an MBA from Clark Atlanta University and a doctorate degree from the University of Georgia.

What is Deretta C. Rhodes' net worth?

The estimated net worth of Deretta C. Rhodes is at least $132.32 thousand as of May 14th, 2025. Dr. Rhodes owns 3,112 shares of Atlanta Braves stock worth more than $132,322 as of December 5th. This net worth evaluation does not reflect any other investments that Dr. Rhodes may own. Learn More about Deretta C. Rhodes' net worth.

How do I contact Deretta C. Rhodes?

The corporate mailing address for Dr. Rhodes and other Atlanta Braves executives is 12300 Liberty Boulevard, Englewood CO, 80112. Atlanta Braves can also be reached via phone at (720) 875-5400 and via email at [email protected]. Learn More on Deretta C. Rhodes' contact information.

Has Deretta C. Rhodes been buying or selling shares of Atlanta Braves?

Deretta C. Rhodes has not been actively trading shares of Atlanta Braves during the last ninety days. Most recently, Deretta C. Rhodes sold 5,000 shares of the business's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $41.20, for a transaction totalling $206,000.00. Following the completion of the sale, the executive vice president now directly owns 3,112 shares of the company's stock, valued at $128,214.40. Learn More on Deretta C. Rhodes' trading history.

Who are Atlanta Braves' active insiders?

Atlanta Braves' insider roster includes Malcolm Gilchrist (Director), Gregory Maffei (CEO, President & Chairman of the Board), John Malone (Chairman), David Rapley (Director), Deretta Rhodes (EVP), Brian Wendling (CAO), and Andrea Wong (Director). Learn More on Atlanta Braves' active insiders.

Are insiders buying or selling shares of Atlanta Braves?

In the last year, Atlanta Braves insiders bought shares 15 times. They purchased a total of 208,233 shares worth more than $8,647,157.24. In the last year, insiders at the financial services provider sold shares 12 times. They sold a total of 221,072 shares worth more than $9,619,809.99. The most recent insider tranaction occured on November, 18th when Major Shareholder John C Malone bought 4,631 shares worth more than $194,455.69. Insiders at Atlanta Braves own 5.9% of the company. Learn More about insider trades at Atlanta Braves.

Information on this page was last updated on 11/18/2025.

Deretta C. Rhodes Insider Trading History at Atlanta Braves

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2025Sell5,000$41.20$206,000.003,112View SEC Filing Icon  
5/14/2025Sell767$40.97$31,423.993,112View SEC Filing Icon  
See Full Table

Deretta C. Rhodes Buying and Selling Activity at Atlanta Braves

This chart shows Deretta C Rhodes's buying and selling at Atlanta Braves by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Atlanta Braves Company Overview

Atlanta Braves logo
Atlanta Braves Holdings, Inc. owns and operates the Atlanta Braves Major league baseball club. It also operates mixed-use development project, including retail, office, hotel, and entertainment projects. The company was incorporated in 2022 and is based in Englewood, Colorado.
Read More

Today's Range

Now: $42.52
Low: $42.05
High: $42.60

50 Day Range

MA: $43.15
Low: $41.92
High: $45.66

2 Week Range

Now: $42.52
Low: $38.67
High: $50.50

Volume

37,620 shs

Average Volume

57,197 shs

Market Capitalization

$2.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62